Skip to content
10-Q

Quarterly Report

cbdMD, Inc. YCBD

0001437749-26-004343

← back to feed
Filed
Feb 17, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Feb 17, 2026 10.5M sh
Capex Q1 2025 · Dec 31, 2025 $164.8K
Capex Q1 2025 · Dec 31, 2024 $164.39K
Operating Cash Flow Q1 2025 · Dec 31, 2025 −$812.46K
Operating Cash Flow Q1 2025 · Dec 31, 2024 −$317.95K
Cash And Equivalents Q1 2025 · Dec 31, 2025 $3.39M
Cash And Equivalents Q1 2025 · Sep 30, 2025 $2.26M
Stockholders Equity Q1 2025 · Dec 31, 2025 $9.01M
Stockholders Equity Q1 2025 · Sep 30, 2025 $7.23M
Stockholders Equity Q1 2025 · Dec 31, 2024 $1.78M
Stockholders Equity Q1 2025 · Sep 30, 2024 $1.96M
Current Liabilities Q1 2025 · Dec 31, 2025 $2.77M
Current Liabilities Q1 2025 · Sep 30, 2025 $3.19M
Total Liabilities Q1 2025 · Dec 31, 2025 $2.77M
Total Liabilities Q1 2025 · Sep 30, 2025 $3.19M
Current Assets Q1 2025 · Dec 31, 2025 $8.17M
Current Assets Q1 2025 · Sep 30, 2025 $6.55M
Total Assets Q1 2025 · Dec 31, 2025 $11.78M
Total Assets Q1 2025 · Sep 30, 2025 $10.42M
Eps Basic Q1 2025 · Dec 31, 2025 −$0.04
Eps Basic restated Q1 2025 · Dec 31, 2024 −$1.73
Net Income Q1 2025 · Dec 31, 2025 −$283.13K
Net Income Q1 2025 · Dec 31, 2024 $15.1K
Operating Income Q1 2025 · Dec 31, 2025 −$286.29K
Operating Income Q1 2025 · Dec 31, 2024 −$86.27K
Gross Profit Q1 2025 · Dec 31, 2025 $3M
Gross Profit Q1 2025 · Dec 31, 2024 $3.4M
Cost Of Revenue Q1 2025 · Dec 31, 2025 $2.02M
Cost Of Revenue Q1 2025 · Dec 31, 2024 $1.71M
Revenue Q1 2025 · Dec 31, 2025 $5.02M
Revenue Q1 2025 · Dec 31, 2024 $5.11M